Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 483 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
483
Total Funding
$1.4B
Avg Funding
$55.7M
Cities
24

Export 483 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Sarasota, United States
$4.0M
raised

NAYA Biosciences is an agile and synergistic platform that provides access to the next generation of biotechnologies.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$350.0M
raised

Belite Bio is a clinical stage biopharmaceutical drug development company.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Matawan, United States
$100.0M
raised

Apimeds Pharmaceuticals is a company that develops therapeutic application solutions for honeybee venom used for inflammatory conditions.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$19.8M
raised

Unlocking the next generation of biotech solutions.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Miami Beach, United States
$60.0M
raised

Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Douglas, United Kingdom
$1.3M
raised

Agronomics is an investment business that focuses on the environmentally sustainable prospects within the burgeoning food industry.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oakville, Canada
$18K
raised

FendX Technologies is a technology company developing surface protection products that protect surfaces from pathogen contamination.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$125.0M
raised

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Newport Beach, United States
$22.0M
raised

AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lyon, France
$10.6M
raised

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Beltsville, United States
$21.5M
raised

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New Haven, United States
$200.0M
raised

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$250.0M
raised

Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Houston, United States
$7.0M
raised

Salarius Pharmaceuticals is an oncology-based biotechnology company developing new therapies to address gene dysregulation.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$71K
raised

Biotechnology company that leverages Artificial Intelligence, DNA, microbiome and epigenetic data for alternative health solutions.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Clermont-ferrand, France
$5.8M
raised

Carbios designs and develops bio-industrial solutions to reinvent the life cycle of plastic and textile polymers.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Halifax, Canada
$532K
raised

Appili Therapeutics is an anti-infective pharmaceutical development company.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$11.0M
raised

FluoGuide provides solutions for maximizing surgical outcome through intelligent targeting.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Norwalk, United States
$4.0M
raised

Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Miami, United States
$25.2M
raised

Veru is a biopharmaceutical company that specializes in developing novel medicines.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Kelowna, Canada
$358K
raised

Rize Oncology develops a platform that allows to conjugate or tether donor DNA templates.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$325K
raised

Glow LifeTech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Malmö, Sweden
$3.2M
raised

Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Milano, Italy
$15.0M
raised

Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$155.3M
raised

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 226 to 250 of 483 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 483 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked